Healthcare -
Biotechnology - NASDAQ - US
$ 35.06
-9.8 %
$ 3.29 B
Market Cap
-5.57
P/E
RARE - TOTAL ASSETS
Total Assets RARE - Ultragenyx Pharmaceutical Inc.
1.5 B
LAST VALUE
-1.37%
2 YEAR CAGR
5.77%
5 YEAR CAGR
22.48%
10 YEAR CAGR